NF1

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas

Interventions for Reading Disabilities in NF1

A Study of Avutometinib for People With Solid Tumor Cancers

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).

Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1

Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1

A Phase II Trial of Poly-ICLC for Low-Grade Gliomas

FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas

Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1

Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults

A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)

Study of Plexiform Neurofibromas in Neurofibromatosis Type 1

Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I

Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas

Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas